Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Mitoxantrone × Clear all

Phase

Phase 1 2 Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 21 Leukemia 14 Lymphoma 9 Leukemia, Erythroblastic, Acute 8 Prostatic Neoplasms 7 Leukemia, Myelomonocytic, Acute 7 Leukemia, Monocytic, Acute 7 Leukemia, Megakaryoblastic, Acute 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Myelodysplastic Syndromes 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Lymphoma, Non-Hodgkin 4 Lymphoma, Large-Cell, Immunoblastic 4 Anemia, Refractory, with Excess of Blasts 4 Leukemia, Promyelocytic, Acute 3 Congenital Abnormalities 3 Breast Neoplasms 3 Pain 2 Neutropenia 2 Myeloproliferative Disorders 2 Leukemia, Myelomonocytic, Chronic 2 Sarcoma, Myeloid 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Neoplasm, Residual 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1

Interventions

Paclitaxel 19 Dexamethasone 16 Bevacizumab 16 Oxaliplatin 14 Docetaxel 14 Cyclophosphamide 12 Capecitabine 12 Gemcitabine 11 Sorafenib 10 Leucovorin 10 Fluorouracil 10 Carboplatin 10 Epoetin Alfa 9 pembrolizumab 8 Pemetrexed 8 Fentanyl 8 venetoclax 7 atezolizumab 7 Rivaroxaban 7 Prednisone 7 Drug Therapy 7 Doxorubicin 7 Anastrozole 7 Rituximab 6 Ondansetron 6 Morphine 6 Irinotecan 6 Denosumab 6 Cisplatin 6 Tranexamic Acid 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00417079 2011-03-10

TROPIC

Sanofi

Phase 3 Completed

755 enrolled 19 charts

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡